Difference between revisions of "Team:METU Turkey/Project"

(Created page with "<html> <head> <style> .highlightBox { width: 570px; background-color: #A0E0A9; padding: 15px; margin: auto; } #content { position: relative; widt...")
 
 
(2 intermediate revisions by the same user not shown)
Line 31: Line 31:
 
}
 
}
  
#content2 {
+
 
    position: relative;
+
    width: 1950px;
+
    margin: 0 auto;
+
    padding: 5px 5px 5px 5px;
+
    background: white;
+
    color: black;
+
    border-radius: 0px;
+
 
+
    line-height: 1.5em;
+
    z-index: 2;
+
 
+
}
+
  
 
body {
 
body {
Line 53: Line 41:
 
}
 
}
 
      
 
      
    #rcorners1 {
+
   ul.nav {
    border-radius: 25px;
+
    background: #FFCE76;
+
    padding: 20px;
+
    width: 100px;
+
    height: 30px;    
+
}
+
    #rcorners1:hover {
+
    border-radius: 25px;
+
    background:#E8C560;
+
    padding: 20px;
+
    width: 100px;
+
    height: 30px;   
+
}
+
    a.one:link {color:2F6CB2;text-decoration:none;}
+
a.one:visited {color:#0000ff;text-decoration:none;}
+
a.one:hover {color:#FFE9C2;text-decoration:none;}
+
 
      
 
      
     p.ex {
+
     background-color: #FFCE76;
    width: 270px;
+
     padding: 3px;
     padding: 0px;
+
     font-size: 17px;
     margin: 0;
+
}
+
   
+
    li {
+
    display: inline;
+
}
+
   
+
    img.ex {
+
    margin-left: 50px;
+
 
}
 
}
  
     .floating-box {
+
     ul.nav li a {
    align: center;
+
        display: block;
    width: 600px;
+
        text-decoration: none;  
    margin: 50px;
+
        padding-bottom: 3px;  
     
+
        padding-top: 3px;
}
+
        padding-right: 9px;
    h1.ex {
+
        padding-left: 9px;
    margin-left: 50px     
+
        background-color: #FFCE76
 +
       
 
     }
 
     }
   
 
    .after-box {
 
    clear: left; 
 
}
 
  
 +
    ul.nav > li:hover {
 +
       
 +
        background-color: #FFE9C2
 +
       
 +
    }
 +
 +
    ul.nav li a:hover {
 +
        background: #ccc;
 +
        background-color: #FFE9C2
 +
       
 +
    }
 +
 +
    ul.nav > li {
 +
        display: inline-block;
 +
        position: relative;
 +
        background-color: #FFCE76
 +
       
 +
    }
 +
 +
    ul.nav > li ul {
 +
        display: none;
 +
        position: absolute;
 +
        left: -1px;
 +
        background-color: #FFCE76;
 +
        border-top-color: #fff;
 +
        margin-top: 0px;
 +
        width: 180px;
 +
    }
 +
 +
    ul.nav > li:hover ul {
 +
        display: block;
 +
    }
 +
 +
    ul.nav > li ul li {
 +
        display: inline-block;
 +
    }
 +
 +
a.one:link {color:#0E2036;text-decoration:none;}
 +
a.one:visited {color:#214D7F;text-decoration:none;}
  
  
Line 110: Line 109:
 
<body>
 
<body>
 
      
 
      
     <div id="content">
+
     <ul class="nav">
    <table style="color:black;" class="sansserif" align=center>
+
        <li>
         <tr>
+
            <a class="one" href="https://2015.igem.org/Team:METU_Turkey">Home</a>
<td id="rcorners1" align=center > <a class="one" href="https://2015.igem.org/Team:METU_Turkey">HOME</a></td>
+
         </li>
<td id="rcorners1" align=center> <a class="one" href="https://2015.igem.org/Team:METU_Turkey/Team">TEAM</a> </td>
+
        <li>
<td id="rcorners1" align=center><a class="one" href="https://2015.igem.org/Team:METU_Turkey/Project">PROJECT</a></td>
+
            <a class="one" href="https://2015.igem.org/Team:METU_Turkey/Team">Team</a>
<td id="rcorners1" align=center><a class="one" href="https://2015.igem.org/Team:METU_Turkey/Parts">PARTS</a></td>
+
         
<td id="rcorners1" align=center><a class="one" href="https://2015.igem.org/Team:METU_Turkey/Notebook">NOTEBOOK</a></td>
+
        </li>
<td id="rcorners1" align=center><a class="one" href="https://2015.igem.org/Team:METU_Turkey/Attributions">ATTRIBUTIONS</a></td>
+
        <li>
</tr>
+
            <a class="one" href="https://2015.igem.org/Team:METU_Turkey/Description">Project</a>
         <tr>
+
            <ul>
<td id="rcorners1" align=center><a class="one" href="https://2015.igem.org/Team:METU_Turkey/Collaborations">COLLABORATIONS</a></td>
+
                <li><a href="https://2015.igem.org/Team:METU_Turkey/Experiments">Experiments</a></li>
<td id="rcorners1" align=center><a class="one" href="https://2015.igem.org/Team:METU_Turkey/Practices">POLICY & PRACTICE</a></td>
+
                <li><a href="https://2015.igem.org/Team:METU_Turkey/Results">Results</a></li>
<td id="rcorners1" align=center><a class="one" href="https://2015.igem.org/Team:METU_Turkey/Safety">SAFETY</a></td>
+
                <li><a href="https://2015.igem.org/Team:METU_Turkey/Design">Design</a></li>
<td id="rcorners1" align=center><a class="one" href="https://2015.igem.org/Team:METU_Turkey/Modeling">MODELING</a></td>
+
            </ul>
<td id="rcorners1" align=center><a class="one" href="https://2015.igem.org/Team:METU_Turkey/Measurement">MEASUREMENT</a></td>
+
        </li>
<td id="rcorners1" align=center><a class="one" href="https://2015.igem.org/Team:METU_Turkey/Entrepreneurship">ENTREPRENEURSHIP</a></td>
+
        <li>
</tr>
+
            <a class="one" href="https://2015.igem.org/Team:METU_Turkey/Parts">Parts</a>
     </table>
+
            <ul>
 +
                <li><a href="https://2015.igem.org/Team:METU_Turkey/Basic_Part">Basic Part</a></li>
 +
                <li><a href="https://2015.igem.org/Team:METU_Turkey/Composite_Part">Composite Part</a></li>
 +
                <li><a href="https://2015.igem.org/Team:METU_Turkey/Part_Collection">Part Collection</a></li>
 +
            </ul>
 +
            </li>
 +
        <li>
 +
            <a class="one" href="https://2015.igem.org/Team:METU_Turkey/Notebook">Notebook</a>
 +
        </li>
 +
        <li>
 +
            <a class="one" href="https://2015.igem.org/Team:METU_Turkey/Attributions">Attributions</a>
 +
        </li>
 +
         <li>
 +
            <a class="one" href="https://2015.igem.org/Team:METU_Turkey/interlab">Interlab</a>
 +
        </li>
 +
        <li>
 +
            <a class="one" href="https://2015.igem.org/Team:METU_Turkey/Collaborations">Collaborations</a>
 +
        </li>
 +
        <li>
 +
            <a class="one" href="https://2015.igem.org/Team:METU_Turkey/Practices">Human Practices</a>
 +
        </li>
 +
        <li>
 +
            <a class="one" href="https://2015.igem.org/Team:METU_Turkey/Safety">Safety</a>
 +
        </li>
 +
        <li>
 +
            <a class="one" href="https://2015.igem.org/Team:METU_Turkey/Modeling">Modeling</a>
 +
        </li>
 +
        <li>
 +
            <a class="one" href="https://2015.igem.org/Team:METU_Turkey/Measurement">Measurement</a>
 +
        </li>
 +
        <li>
 +
            <a class="one" href="https://2015.igem.org/Team:METU_Turkey/Gallery">Gallery</a>
 +
        </li>
 +
        <li>
 +
            <a class="one" href="https://2015.igem.org/Team:METU_Turkey/Sponsors">Sponsors</a>
 +
        </li>
 +
   
 +
        </li>
 +
     </ul>
  
<img align=center src="https://static.igem.org/mediawiki/2015/f/f9/LO_ODTU_METU_ACIK_RENKLI_ZEMIN.png" width=100%></br>
+
<!-- First block of content -->
 +
<table  cellspacing="20px" height="150px" align="center">
 +
<tr>
 +
<td align="center" width="350px"><a href="https://igem.org/Main_Page"> <img src="https://static.igem.org/mediawiki/igem.org/6/60/Igemlogo_300px.png" width="150px"></a></td>
 +
 
 +
<td align="center" bgColor="#FFFFFF" >
 +
 
 +
<!-- You can replace this image with your team's logo! -->
 +
<img src="https://static.igem.org/mediawiki/2014/c/cc/Metuigem_logo.png" width="120px">
 +
<h3>Welcome!  <br> We are Team METU_Turkey! </h3>
 +
 
 +
</td>
 +
<td align="center" width="162px"><a href="http://www.metu.edu.tr"color:#FFFFFF"><img src="https://static.igem.org/mediawiki/2014/9/91/Metulogo.jpg" width="300px"></a></td>
 +
</tr>
 +
</table>
 +
<!-- end of first block -->
  
  
Line 140: Line 192:
 
<div class="highlightBox">
 
<div class="highlightBox">
 
<h2 align=center>Project Description</h2>
 
<h2 align=center>Project Description</h2>
<p align=center>As an autoimmune disorder, celiac disorder depends on sensitivity to wheat ingredients such that gliadin which is a glycoprotein complex rich in proline and glutamine, especially alpha-2-gliadin. Alfa-2-glaidin basically bind to of specific receptor called HLA-DQ2 or HLA-DQ8 (because tTG alter the alfa-2-gliadin’s charge density which results in highly negative charges. This negative charge density create significant binding effect of alfa-2-gliadin to HLA-DQ2 OR HLA-DQ8 ). That receptor is an important key component of immune system, which have loci at chromosome 6. Epitopes of that receptor create cellular signaling pathway which results in arise of T and B-cells. These important immune cells eventually kill the specific antigens presented cells. Thus, in order to interfere this autoimmune disorder, protein’s (gluten) specific subunits, which have key roles at celiac disorder are going to be destroyed before the intake of protein in our project. Fundamentally, adding specific enzymes’ genes to E.coli’s genome. Then, E.coli will be added into dough while it is in fermentation process. So during the process of fermentation, specific enzymes’ genes will be transcribed and break down the gluten. To sum up, with the specific enzyme, which is expressed by E.coli, alters and break down the specific protein subunit which is key component of celiac disorder. In addition, we would like to improve the stiffness of gluten-free bread by letting bacteria to secrete additives. For the efficiency of the gluten destruction process, the homogenization of dough will be also improved by the bacteria secretion of additives. Last but not least, receptor complex within E.coli is going to be designed and enable bacteria to express receptor which is like HLA-DQ; in order to detect whether there is a gluten or not.</p>
+
<p align=center>As an autoimmune disease, celiac disease is sensitivity to grains such as wheat rye and barley that have gliadin which is a glycoprotein complex rich in proline and glutamine, especially alpha-2-gliadin. Alfa-2-glaidin basically binds to a specific receptor called HLA-DQ2 or HLA-DQ8. This is because tTG alter the alfa-2-gliadin’s charge density which results in highly negative charges. This negative charge density creates significant binding effect to alfa-2-gliadin to HLA-DQ2 OR HLA-DQ8. This receptor is an important key component of the  immune system, which has loci at chromosome 6. Epitopes of that receptor create cellular signaling pathway which results in increase of T and B-cells. These important immune cells eventually kill the specific antigens presented cells. Thus, in order to prevent  this autoimmune disorder, our project aims to destroy these specific subunits of gluten before the intake of food. This will be accomplished by adding specific enzymes’ genes to E.coli’s genome. Then, E.coli will be added into dough while it is in fermentation process. So during the process of fermentation, specific enzymes’ genes will be transcribed and they will break down the gluten. To sum up, with the specific enzyme, which is expressed by E.coli, will alter and brake down the specific protein subunit which is a key component of celiac disease, . In addition, we would like to improve the consistency of gluten-free bread by letting bacteria secrete additives. For the efficiency of the gluten destruction process, the homogenization of dough will also be improved by the bacteria secretion of additives. Last but not least, receptor complex within E.coli is going to be designed and this  will enable the bacteria to express a receptor which is like HLA-DQ; in order to detect whether there is a gluten or not.
 +
</p>
 
</div>
 
</div>
 
</tr>
 
</tr>
 
</table>
 
</table>
 +
 +
 +
 +
<!-- Sponsorlar beginning -->
 +
    <table  id="firstblock" width="60%"  cellspacing="10px" height="200px" align="center">
 +
        <tr>
 +
        <td align=center>
 +
<a href="http://www.metu.edu.tr"> <img src="https://static.igem.org/mediawiki/2014/9/91/Metulogo.jpg" width="350px" align="center"></a>
 +
        </td>
 +
        </tr>
 +
           
 +
    </table>
 +
 +
<table  id="firstblock" width="60%"  cellspacing="10px" height="200px" align="center">
 +
 +
 +
<tr>
 +
 +
<td align="center" width="162px"><a href="http://odtuteknokent.com.tr/"> <img src="https://static.igem.org/mediawiki/2014/4/47/Odtuteknokent.jpg" width="175px"></a></td>
 +
 +
<td align="center" width="162px"><a href="http://www.kardiosis.com.tr/"> <img src="https://static.igem.org/mediawiki/2014/d/d4/Kardiosis.jpg" width="175px"></a></td>
 +
 +
<td align="center" width="162px"><a href="http://www.tr-idea.com/"> <img src="https://static.igem.org/mediawiki/2015/c/c6/METU_Turkey_Idea.PNG" width="350px"></a></td>
 +
 +
</tr>
 +
</table>
 +
<table align="center" cellspacing="10px">
 +
<tr>
 +
 +
<td align="center"><a href="http://www.sentegen.com/"> <img src="https://static.igem.org/mediawiki/2014/d/dd/Sentegenlogoder.PNG" width="175px"></a></td>
 +
 +
 +
 +
 +
<td align="center"><a href="http://www.mathworks.com/"> <img src="https://static.igem.org/mediawiki/2015/a/ab/METU_Turkey_mathworks.png" width="175px"></a></td>
 +
 +
 +
</tr>
 +
</table>
 +
 +
   
 +
<!-- Sponsorlar end -->
 
</body>
 
</body>
 
</html>
 
</html>

Latest revision as of 05:30, 7 September 2015

Welcome!
We are Team METU_Turkey!

Project Description

As an autoimmune disease, celiac disease is sensitivity to grains such as wheat rye and barley that have gliadin which is a glycoprotein complex rich in proline and glutamine, especially alpha-2-gliadin. Alfa-2-glaidin basically binds to a specific receptor called HLA-DQ2 or HLA-DQ8. This is because tTG alter the alfa-2-gliadin’s charge density which results in highly negative charges. This negative charge density creates significant binding effect to alfa-2-gliadin to HLA-DQ2 OR HLA-DQ8. This receptor is an important key component of the immune system, which has loci at chromosome 6. Epitopes of that receptor create cellular signaling pathway which results in increase of T and B-cells. These important immune cells eventually kill the specific antigens presented cells. Thus, in order to prevent this autoimmune disorder, our project aims to destroy these specific subunits of gluten before the intake of food. This will be accomplished by adding specific enzymes’ genes to E.coli’s genome. Then, E.coli will be added into dough while it is in fermentation process. So during the process of fermentation, specific enzymes’ genes will be transcribed and they will break down the gluten. To sum up, with the specific enzyme, which is expressed by E.coli, will alter and brake down the specific protein subunit which is a key component of celiac disease, . In addition, we would like to improve the consistency of gluten-free bread by letting bacteria secrete additives. For the efficiency of the gluten destruction process, the homogenization of dough will also be improved by the bacteria secretion of additives. Last but not least, receptor complex within E.coli is going to be designed and this will enable the bacteria to express a receptor which is like HLA-DQ; in order to detect whether there is a gluten or not.